Yarrow Bioscience (YARW) Operating Leases (2019 - 2024)
Yarrow Bioscience's (YARW) quarterly Operating Leases came in at $99000.0 in Q4 2024, little changed YoY from $99000.0 in Q1 2024, and up 296.0% on a QoQ basis from $25000.0 in Q2 2024.
Yarrow Bioscience (YARW) Operating Leases (2019 - 2024) Analysis & Trends
Yarrow Bioscience (YARW) has 5 years of Operating Leases data on file, last reported at $99000.0 in Q4 2024.
- Quarterly Operating Leases changed 0.0% year-over-year to $99000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $99000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $99000.0, changed 0.0% from the prior year.
- Operating Leases advanced to $99000.0 in Q4 2024, from $25000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.2 million in Q3 2020 to a low of $25000.0 in Q2 2024.
- A 4-year average of $762000.0 and a median of $775000.0 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2020 — Operating Leases soared 630.0% — and 2021, when it tumbled 64.61%.
- Tracing YARW's Operating Leases over 4 years: stood at $853000.0 in 2020, then fell by 9.14% to $775000.0 in 2021, then tumbled by 87.23% to $99000.0 in 2023, then changed by 0.0% to $99000.0 in 2024.
- The last three Operating Leases figures came in at $99000.0 (Q4 2024), $25000.0 (Q2 2024), and $63000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Yarrow Bioscience | 32.54 Mn | 9.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 99,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2021 | 775,000.00 |
| Jun 30, 2021 | 812,000.00 |
| Mar 31, 2021 | 1.43 Mn |
| Dec 31, 2020 | 853,000.00 |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2020 | 727,000.00 |
| Dec 31, 2019 | 653,000.00 |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 715,000.00 |
| Mar 31, 2019 | 684,000.00 |